Updates on Palliative Radiotherapy for Dysphagia in Esophageal Cancer

Difficulty swallowing is one of the most distressing complications of advanced oesophageal cancer. It can lead to dehydration, weight loss, aspiration and loss of independence, so treatment decisions often need to balance rapid relief against durability, travel, toxicity and a person’s overall goals of care.

Palliative radiotherapy has an important role, although it is not the right first intervention for every patient. Modern planning, shorter treatment schedules and closer coordination with stenting, nutrition and systemic therapy have made symptom control more individualised. The virtual ISDE 2021 congress highlighted the value of evidence-based multidisciplinary decision-making in this setting.

Why Dysphagia Needs Rapid Relief

Tumour growth can narrow the oesophageal lumen, while inflammation, spasm and treatment-related swelling can worsen swallowing. Patients may move from difficulty with solid food to problems with liquids within a short period. Assessment should include hydration, nutritional status, aspiration risk, pain, bleeding and the possibility of a fistula.

A dietitian, speech pathologist, gastroenterologist, radiation oncologist and medical oncologist can help identify the safest route. Endoscopy or imaging may be needed before placing a stent or planning radiation. In Australia, care is often organised through a public hospital multidisciplinary team, while private oncology services may provide treatment closer to home in cities such as Sydney, Melbourne, Brisbane, Perth and Adelaide.

Choosing Between Radiotherapy And Stenting

A stent generally offers the fastest improvement when a patient cannot swallow fluids or needs urgent oral intake. Its disadvantages include reflux, chest discomfort, migration and recurrent blockage. Careful positioning is particularly important when the tumour is near the gastro-oesophageal junction or upper oesophageal sphincter.

External-beam radiotherapy is more attractive when symptoms are significant but not immediately life-threatening and the patient may live long enough to benefit from durable local control. Common palliative schedules include 20 Gy in five fractions or 30 Gy in ten fractions, although treatment is tailored to anatomy, previous radiation, performance status and local protocols. A single fraction can be considered for selected frail patients, but symptom durability may be shorter.

What Recent Evidence Shows

Studies presented and discussed around the ISDE 2021 period reinforced that radiotherapy should not automatically be added after every stent. The randomised ROCS study found no clear improvement in dysphagia-related quality of life from routine external-beam radiotherapy after stent placement. This supports selective use rather than a blanket approach.

Radiation can still help with tumour-related dysphagia, bleeding and pain when there is no urgent obstruction. Brachytherapy, which places a radioactive source close to the tumour, may provide longer-lasting relief in carefully selected patients, but it requires specialised expertise and suitable anatomy. Evidence comparing techniques remains limited, so treatment should reflect patient priorities and local experience.

Factors Supporting A Treatment Choice

• Speed of symptom relief required
• Expected survival and functional status
• Previous surgery, chemotherapy or radiotherapy
• Access to endoscopy and radiation services

Planning Treatment Around Patient Priorities

The aim is usually to preserve comfortable swallowing for as long as possible, rather than to achieve radiological tumour shrinkage alone. A person who wants to attend family events, continue eating small meals or avoid hospital travel may choose a different treatment from someone prioritising the quickest possible relief.

Radiotherapy planning should consider the dose to the heart, lungs and remaining oesophagus. Intensity-modulated techniques can help shape the dose, although the benefit must be weighed against planning time and treatment complexity. Concurrent chemotherapy is generally avoided when the goal is symptom palliation unless there is a specific oncological reason.

Nutrition support should begin early. Soft, moist foods, oral supplements and texture modification may help during treatment, while a feeding tube can be considered when oral intake is unsafe or inadequate. Australian patients living regionally may use travel and accommodation programs to attend a metropolitan radiation centre, with telehealth helping coordinate follow-up.

Managing Side Effects And Access

Radiation oesophagitis can cause worsening pain on swallowing, heartburn or a temporary reduction in intake. Symptoms often appear several days after treatment and may peak after treatment has finished. Analgesia, acid suppression, antiemetics and dietetic advice should be arranged before symptoms intensify. New breathlessness, fever, severe chest pain or inability to swallow liquids requires urgent review.

Radiation services in Australia operate under state and territory safety requirements, while medicines and many medical devices are regulated nationally through the Therapeutic Goods Administration. Public treatment is generally supported through Medicare arrangements, though eligibility, waiting times and local referral pathways vary. Patients should receive clear information about costs, transport, accommodation and who to contact outside business hours.

Practical Support During Treatment

• Keep a written record of fluids, supplements and swallowing changes
• Take prescribed pain relief before meals when advised
• Report coughing during drinks or recurrent chest infections
• Confirm follow-up timing before leaving the radiation department

Matching Treatment To Real-World Goals

The most suitable plan depends on the urgency of obstruction, tumour location, anticipated survival, previous treatment and the patient’s willingness to undergo procedures. A stent may be preferable for immediate relief, while radiotherapy may offer better control when there is time for the effect to develop. Combining both can be reasonable in selected cases, but routine post-stent radiation is not supported for everyone.

For Australians, practical factors deserve equal attention to the clinical evidence. Long journeys from regional Queensland, Western Australia or Tasmania can make a short radiation course preferable, while local access to endoscopy may determine whether a stent is feasible. The safest plan is one agreed by the multidisciplinary team, documented in plain language and reviewed when swallowing, nutrition or goals of care change.

The practical takeaway is to treat dysphagia urgently, compare the speed and durability of each option, and align palliative radiotherapy with the patient’s symptoms, prognosis, access to care and personal priorities.